title: Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer.
abstract: The majority (∼70%) of breast cancers are steroid hormone receptor (SR) positive at the time of diagnosis. Endocrine therapies that target estrogen receptor α (ERα) action (tamoxifen, toremifene, fulvestrant) or estrogen synthesis (aromatase inhibitors: letrozole, anastrozole, exemestane; or ovarian suppression) are a clinical mainstay. However, up to 50% of SR+ breast cancers exhibit de novo or acquired resistance to these clinical interventions. Mechanisms of resistance to endocrine therapies often include upregulation and/or activation of signal transduction pathways that input to cell cycle regulation. Cyclin D1, the regulatory subunit of cyclin-dependent protein kinases four and six (CDK4/6) serves as a convergence point for multiple signaling pathways. In a recent paper entitled 'Therapeutically Activating Retinoblastoma (RB): Reestablishing Cell Cycle Control in Endocrine Therapy-Resistant Breast Cancer', Thangavel et al. reported maintenance of cyclin D1 expression and RB phosphorylation in the face of ER ablation in multiple breast cancer cell line models of endocrine resistance. RB-dysfunction defined a unique gene signature that was associated with luminal B-type breast cancer and predictive of poor response to endocrine therapies. Notably, a new CDK4/6 inhibitor (PD-0332991) was capable of inducing growth arrest by a mechanism that was most consistent with cellular senescence. In this review, these findings are discussed in the context of SRs as important mediators of cell cycle progression, and the frequent loss of cell cycle checkpoint control that typifies breast cancer progression. These studies provide renewed hope of effectively stabilizing endocrine-resistant breast cancers using available complementary (to endocrine-based therapies) cytostatic agents in the form of CDK4/6 inhibitors.
authors: Departments of Medicine and Pharmacology, Masonic Cancer Center, University of Minnesota, 420 Delaware Street South East, MMC 806, Minneapolis, Minnesota 55455, USA. lange047@umn.edu
authors: Carol A
authors: CA
authors: Lange
authors: Douglas
authors: D
authors: Yee
references: J Mammary Gland Biol Neoplasia. 1998 Jan;3(1):63-72
references: 10819505
references: Mech Ageing Dev. 2011 Apr;132(4):180-6
references: 21453717
references: Cell Signal. 2010 Jul;22(7):1003-12
references: 20100570
references: Endocr Relat Cancer. 2011 Apr 28;18(3):333-45
references: 21367843
references: Cell Cycle. 2011 Mar 15;10(6):956-62
references: 21358261
references: J Clin Oncol. 2007 Sep 1;25(25):3816-22
references: 17679728
references: Biochem Soc Trans. 2010 Feb;38(Pt 1):217-22
references: 20074063
references: Cell Cycle. 2010 Feb 15;9(4):689-99
references: 20107323
references: Oncogene. 2011 Jun 30;30(26):2901-11
references: 21383691
references: World J Surg Oncol. 2010 Dec 22;8:111
references: 21176227
references: Breast Cancer Res. 2009;11(5):R77
references: 19874578
references: Clin Cancer Res. 2007 Oct 1;13(19):5834-40
references: 17908976
references: PLoS One. 2010 Jun 08;5(6):e11011
references: 20543978
references: Cancer Res. 2006 Dec 1;66(23):11478-84
references: 17145896
references: Mol Cell Biol. 1996 Dec;16(12):6917-25
references: 8943347
references: J Clin Oncol. 2009 Nov 20;27(33):5529-37
references: 19786670
references: Hum Cell. 2008 May;21(2):28-37
references: 18397472
references: J Steroid Biochem Mol Biol. 2007 Aug-Sep;106(1-5):180-6
references: 17624764
references: Biochim Biophys Acta. 1999 Oct 29;1424(2-3):M17-22
references: 10528151
references: Trends Endocrinol Metab. 2009 Dec;20(10):477-82
references: 19783454
references: J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):169-74
references: 9699870
references: Eur J Cancer Clin Oncol. 1983 May;19(5):615-21
references: 6683633
references: J Clin Oncol. 2009 Nov 20;27(33):5538-46
references: 19786658
references: Expert Opin Ther Targets. 2010 Nov;14(11):1199-212
references: 20932174
references: Science. 1996 Dec 6;274(5293):1672-7
references: 8939849